Available for 35 days
Could personalized cancer vaccines transform melanoma treatment? This week, Merck & Co. (known as MSD in Europe) and Moderna announced that their individualised mRNA cancer vaccine significantly improved outcomes for people with melanoma. We explore how personalized cancer vaccines work, what the latest clinical trial results mean, and whether they could mark the beginning of a new era in cancer treatment. Anne Willis, a cancer cell biologist at the Medical Research Council, joins the discussion.
The Royal Society Trivedi Book Prize, one of the most prestigious awards for science nonfiction, will be announced in just a few weeks. We speak to the finalists each week, beginning with Kit Chapman, author of The Age of Alchemy. Plus, Penny Sarche investigates obscure historical documents and scientific journals to uncover the latest developments in science and technology.
Presenter: Tom Whipple
Producer: Alex Mansfield, Tabitha Taylor Buck, Katie Thomsett, Kieran Manetta-Jones
Editor: Ilan Goodman
Production Coordinator: Jana Bennett-Holdsworth
Program website
Source: www.bbc.co.uk